XENOPORT
XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. Horizantยฎ (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in the United States by XenoPort. Regniteยฎ (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in Japan by Astellas Pharma Inc. XenoPort holds all other world-wide rights to gabapentin enacarbil. XenoPort's pipeline of product candidates includes potential treatments for patients with Parkinson's disease, relapsing-remitting multiple sclerosis and psoriasis.
XENOPORT
Industry:
Biotechnology Developer Platform Pharmaceutical
Founded:
1999-01-01
Address:
Santa Clara, California, United States
Country:
United States
Website Url:
http://www.xenoport.com
Total Employee:
251+
Status:
Active
Contact:
14086167210
Email Addresses:
[email protected]
Total Funding:
143.77 M USD
Technology used in webpage:
GStatic Google Static Content Register.com DNS Network Solutions Omniture SiteCatalyst Cogent Communications Edgar Online
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
![]()
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
![]()
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
![]()
![]()
![]()
![]()
Current Employees Featured
![]()
![]()

![]()
![]()
Founder

Stock Details
Investors List
GGV Capital
GGV Capital investment in Series D - Xenoport
GGV Capital
GGV Capital investment in Series C - Xenoport
Venrock
Venrock investment in Series C - Xenoport
Venrock
Venrock investment in Series B - Xenoport
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Xenoport
![]()
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - Xenoport
Venrock
Venrock investment in Series A - Xenoport
Skyline Ventures
Skyline Ventures investment in Series A - Xenoport
![]()
Alejandro Zaffaroni
Alejandro Zaffaroni investment in Series A - Xenoport
![]()
CMEA Ventures
CMEA Ventures investment in Series A - Xenoport
